Lakeshore Biopharma Co., Ltd. (NASDAQ:LSB) Short Interest Update

Lakeshore Biopharma Co., Ltd. (NASDAQ:LSB) was the recipient of a large decrease in short interest in the month of August. As of August 15th, there was short interest totalling 23,000 shares, a decrease of 12.5% from the July 31st total of 26,300 shares. Based on an average trading volume of 37,400 shares, the days-to-cover ratio is currently 0.6 days. Approximately 0.1% of the shares of the company are sold short.

Lakeshore Biopharma Stock Down 0.0 %

Shares of NASDAQ:LSB opened at $0.44 on Monday. Lakeshore Biopharma has a 12-month low of $0.35 and a 12-month high of $1.45. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.13 and a quick ratio of 0.87.

About Lakeshore Biopharma

LakeShore Biopharma Co, Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001.